- Home
- TLSI vs AEYE Comparison
TLSI vs AEYE Comparison
Compare TLSI & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- AEYE
- Stock Information
- Founded
- TLSI 2010
- AEYE 2005
- Country
- TLSI United States
- AEYE United States
- Employees
- TLSI N/A
- AEYE N/A
- Industry
- TLSI Medical Specialities
- AEYE Computer Software: Prepackaged Software
- Sector
- TLSI Health Care
- AEYE Technology
- Exchange
- TLSI Nasdaq
- AEYE Nasdaq
- Market Cap
- TLSI 160.4M
- AEYE 153.6M
- IPO Year
- TLSI N/A
- AEYE N/A
- Fundamental
- Price
- TLSI $5.74
- AEYE $11.30
- Analyst Decision
- TLSI Strong Buy
- AEYE Strong Buy
- Analyst Count
- TLSI 6
- AEYE 5
- Target Price
- TLSI $11.75
- AEYE $26.10
- AVG Volume (30 Days)
- TLSI 57.4K
- AEYE 141.0K
- Earning Date
- TLSI 05-14-2025
- AEYE 04-29-2025
- Dividend Yield
- TLSI N/A
- AEYE N/A
- EPS Growth
- TLSI N/A
- AEYE N/A
- EPS
- TLSI N/A
- AEYE N/A
- Revenue
- TLSI $29,431,000.00
- AEYE $35,201,000.00
- Revenue This Year
- TLSI $55.08
- AEYE $20.29
- Revenue Next Year
- TLSI $50.75
- AEYE $18.65
- P/E Ratio
- TLSI N/A
- AEYE N/A
- Revenue Growth
- TLSI 58.99
- AEYE 12.41
- 52 Week Low
- TLSI $3.50
- AEYE $8.91
- 52 Week High
- TLSI $10.24
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- TLSI 59.91
- AEYE 46.68
- Support Level
- TLSI $5.23
- AEYE $8.91
- Resistance Level
- TLSI $5.66
- AEYE $11.96
- Average True Range (ATR)
- TLSI 0.34
- AEYE 1.00
- MACD
- TLSI 0.03
- AEYE 0.21
- Stochastic Oscillator
- TLSI 92.94
- AEYE 78.36
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.